We previously also found that the treatment of mTOR inhibitor rapamycin improved novel object recognition memory and rescued LTP deficits in Rab39b KO mice, indicating that rapamycin might alleviate XLID symptoms.12 This evidence concerns the gene RAB39B and cask-related x-linked intellectual disability.